Intense accumulation of F-18-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors
- Authors
- Park, Jong Hoon; Park, Eun Kyung; Kang, Chang Ho; Kim, Chul Hwan; Choe, Jae Gol; Noh, Won
- Issue Date
- 12월-2009
- Publisher
- SPRINGER
- Keywords
- Soft tissue tumor; Sarcoma; FDG PET; MR; Metabolic biopsy
- Citation
- ANNALS OF NUCLEAR MEDICINE, v.23, no.10, pp.887 - 889
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF NUCLEAR MEDICINE
- Volume
- 23
- Number
- 10
- Start Page
- 887
- End Page
- 889
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/134683
- DOI
- 10.1007/s12149-009-0313-x
- ISSN
- 0914-7187
- Abstract
- Soft tissue sarcomas are a highly heterogeneous group of malignancies that arise from mesenchymal tissues. Grading of soft tissue sarcomas is an important prerequisite for the choice of therapy and estimation of prognosis. However, incisional biopsy of huge soft tissue sarcoma lesions frequently fails to provide an accurate diagnosis when there is a benign component, cystic changes and/or necrosis. MRI is helpful in evaluating the extent of the sarcoma lesion, vascularization, invasiveness and integrity of surrounding tissue, but definitive differentiation of benignity and malignancy is not possible with it. In this study, positron emission tomography using [F-18]-2-fluoro-2-deoxy-d-glucose successfully guided surgeons to identify the most hypermetabolic and, therefore, the most suitable biopsy sites of huge soft tissue sarcoma.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.